MPEP § 2412.05 — Representation and Symbols for Nucleotide and/or Amino Acid Sequences (Annotated Rules)
§2412.05 Representation and Symbols for Nucleotide and/or Amino Acid Sequences
This page consolidates and annotates all enforceable requirements under MPEP § 2412.05, including statutory authority, regulatory rules, examiner guidance, and practice notes. It is provided as guidance, with links to the ground truth sources. This is information only, it is not legal advice.
Representation and Symbols for Nucleotide and/or Amino Acid Sequences
This section addresses Representation and Symbols for Nucleotide and/or Amino Acid Sequences.
Key Rules
Sequence Listing Content
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
Citations
| Primary topic | Citation |
|---|---|
| Sequence Listing Content | 37 CFR § 1.831(b) |
Source Text from USPTO’s MPEP
This is an exact copy of the MPEP from the USPTO. It is here for your reference to see the section in context.
Official MPEP § 2412.05 — Representation and Symbols for Nucleotide and/or Amino Acid Sequences
Source: USPTO2412.05 Representation and Symbols for Nucleotide and/or Amino Acid Sequences [R-01.2024]
[Editor Note: This section is applicable to all applications with a filing date, or, for national phase applications, an international filing date, on or after July 1, 2022, having disclosure of one or more nucleotide and/or amino acid sequences as defined in 37 CFR 1.831(b).]
WIPO Standard ST.26 sets forth specific symbols for representing nucleotide and/or amino acid residues in a sequence. The USPTO rules incorporate those specific symbols and XML formatting representations.